Miyamoto K, Nguyen KT, Allen GE, et al. Chromatin Accessibility Impacts Transcriptional Reprogramming in Oocytes. Cell Rep. 2018;24(2):304-311. doi:10.1016/j.celrep.2018.06.030.

Schaub FX, Dhankani V, Berger AC, et al. Pan-cancer Alterations of the MYC Oncogene and Its Proximal Network across the Cancer Genome Atlas. Cell Syst. 2018;6(3):282-300.e2. doi:10.1016/j.cels.2018.03.003.

Younger ST, Rinn JL. p53 regulates enhancer accessibility and activity in response to DNA damage. Nucleic Acids Res. 2017;45(17):9889-9900. doi:10.1093/nar/gkx577.

Gate RE, Cheng CS, Aiden AP, et al. Genetic determinants of co-accessible chromatin regions in activated T cells across humans. Nat Genet. 2018;50(8):1140-1150. doi:10.1038/s41588-018-0156-2.

Barutcu R, Maass PG, Lewandowski JP, Weiner CL, Rinn JL. A TAD boundary is preserved upon deletion of the CTCF-rich Firre locus. Nat Commun. 2018;9(1):1444. doi:10.1038/s41467-018-03614-0.

Nakayama RT, Pulice JL, Valencia AM, et al. SMARCB1 is required for widespread BAF complex-mediated activation of enhancers and bivalent promoters. Nat Genet. 2017;49(11):1613-1623. doi:10.1038/ng.3958.

Oshidari R, Strecker J, Chung DKC, et al. Nuclear microtubule filaments mediate non-linear directional motion of chromatin and promote DNA repair. Nat Commun. 2018;9(1):2567. doi:10.1038/s41467-018-05009-7.

Wang X, Srivastava Y, Jankowski A, et al. DNA-mediated dimerization on a compact sequence signature controls enhancer engagement and regulation by FOXA1. Nucleic Acids Res. 2018;46(11):5470-5486. doi:10.1093/nar/gky259.

Soto-Feliciano YM, Bartlebaugh JME, Liu Y, et al. PHF6 regulates phenotypic plasticity through chromatin organization within lineage-specific genes. Genes Dev. 2017;31(10):973-989. doi:10.1101/gad.295857.117.

Simeonov DR, Gowen BG, Boontanrart M, et al. Discovery of stimulation-responsive immune enhancers with CRISPR activation. Nature. 2017;549(7670):111-115. doi:10.1038/nature23875.